- Home
- UBFO vs INMB Comparison
UBFO vs INMB Comparison
Compare UBFO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBFO
- INMB
- Stock Information
- Founded
- UBFO 1987
- INMB 2015
- Country
- UBFO United States
- INMB United States
- Employees
- UBFO N/A
- INMB N/A
- Industry
- UBFO Major Banks
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- UBFO Finance
- INMB Health Care
- Exchange
- UBFO Nasdaq
- INMB Nasdaq
- Market Cap
- UBFO 162.0M
- INMB 176.5M
- IPO Year
- UBFO N/A
- INMB 2019
- Fundamental
- Price
- UBFO $9.08
- INMB $2.36
- Analyst Decision
- UBFO
- INMB Buy
- Analyst Count
- UBFO 0
- INMB 4
- Target Price
- UBFO N/A
- INMB $9.53
- AVG Volume (30 Days)
- UBFO 112.7K
- INMB 6.3M
- Earning Date
- UBFO 07-17-2025
- INMB 07-31-2025
- Dividend Yield
- UBFO 5.32%
- INMB N/A
- EPS Growth
- UBFO N/A
- INMB N/A
- EPS
- UBFO 0.77
- INMB N/A
- Revenue
- UBFO $47,362,000.00
- INMB $50,000.00
- Revenue This Year
- UBFO N/A
- INMB $82.14
- Revenue Next Year
- UBFO N/A
- INMB $28,750.98
- P/E Ratio
- UBFO $11.67
- INMB N/A
- Revenue Growth
- UBFO N/A
- INMB N/A
- 52 Week Low
- UBFO $7.07
- INMB $1.89
- 52 Week High
- UBFO $10.49
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- UBFO 63.87
- INMB 24.85
- Support Level
- UBFO $8.21
- INMB $1.89
- Resistance Level
- UBFO $8.80
- INMB $11.64
- Average True Range (ATR)
- UBFO 0.32
- INMB 1.18
- MACD
- UBFO 0.09
- INMB -0.57
- Stochastic Oscillator
- UBFO 89.03
- INMB 4.82
About UBFO United Security Bancshares
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.